PPD, Inc. has been selected as a preferred provider to a consortium of 14 global health Product Development Partners (PDPs) to develop medicines for some of the world’s poorest countries. PPD will provide discovery, clinical development and post-approval services for drug and vaccine development for health initiatives for infectious diseases like HIV, tuberculosis and malaria and neglected diseases such as visceral leishmaniasis, Chagas disease and Human African trypanosomiasis. “PPD is comm...